Your session is about to expire
← Back to Search
Hydrolyzed Protein Formula
Hydrolyzed protein infant formula with oligosaccharides for Gastrointestinal Tolerance
N/A
Waitlist Available
Research Sponsored by Abbott Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study day1 to study day 28
Awards & highlights
Study Summary
This trial is testing an infant formula to see if it is effective and safe.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ study day1 to study day 28
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study day1 to study day 28
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Weight Maintenance
Secondary outcome measures
Gastrointestinal Tolerance
Length
Weight
Other outcome measures
Adverse Events
Formula Satisfaction Questionnaire
Health Care Utilization
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Experimental ProductExperimental Treatment1 Intervention
Infant formula product consumed ad libitum as instructed for approximately 28 days; Powder formula mixed to 20 kcal/fl. oz.
Find a Location
Who is running the clinical trial?
Abbott NutritionLead Sponsor
168 Previous Clinical Trials
33,471 Total Patients Enrolled
Carlett RamirezStudy ChairAbbott Nutrition
2 Previous Clinical Trials
246 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have already been given a special type of nutrition formula made from amino acids.You are currently taking steroids in pill or inhaler form.The pregnant mother is suspected of using harmful substances like alcohol or drugs.You have a medical history that could potentially affect your growth or development, or that of your baby if you are pregnant.If you are a baby who is being fed formula, and you are having trouble digesting it or showing signs of a possible food allergy, or if your doctor has recommended a special formula for your specific condition, you may not be eligible for the study.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental Product
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger